BioSpace News Archive

Canopy Growth Corporation is pleased to announce that the Company has acquired Daddy Cann Lesotho PTY Ltd., trading as Highlands.

FDA Grants Orphan Drug Designation for DCR-PHXC for the Treatment of Primary Hyperoxaluria

Technology Enables Clinicians to Non-Invasively Evaluate Brain Blood Flow Characteristics for Management of Patients with Neurological Disease

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has completed enrollment and dosing of all 5 planned cohorts of healthy adult volunteers in the single-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company’s third generation subcutaneously administered RNA interference (RNAi) therapeutic being developed as a potentially curative therapy for patients with chronic hepatitis B virus (HBV) infection

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), today announced positive results from its interim safety analysis as requested by FDA on patients from its Phase 2 clinical trial of AG013 for the treatment of OM.

Hormel Foods announced that the American Heart Association has certified two of the company’s VALLEY FRESH® chicken breast products with the Heart-Check mark to make it easier for consumers to identify heart-healthy foods.

Centene Corporation announced it will present at the Goldman Sachs 39th Annual Global Healthcare Conference.

Financing led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One

AbbVie today announced the preliminary results of its modified Dutch auction tender offer.

In its report, “An Industry Roadmap for Provider Data,” the Provider Data Action Alliance, a group convened by CAQH, concluded that broad industry collaboration is needed to improve provider data.